<annotation text="Abstract Purpose. A prospective longitudinal study was initiated to analyze the correlation between the prognosis for the second eyes of patients with unilateral late exudative AMD and the disease phenotype. Methods. Of the187 patients with unilateral late exudative AMD recruited, 130 (69.5%) had predominantly classic CNV without pigment epithelium detachment (PED) (CNV group), and 57 (30.5%) had occult CNV with serous PED (PED group). Patients were reexamined by ophthalmoscopy and angiography every 6 months for up to 80 months. The end point was ETDRS visual acuity change of 3 lines or more due to late AMD in the second eye. Results. During follow-up 53 (28.3%) patients reached the end point: 32 (24.6%) in the CNV group and 21 (36.8%) in the PED group. The major prognostic factor for the risk of visual loss in the second eye was the type of late AMD in the first eye (CNV group 6–7% per year, PED group 15–16% per year (P&lt;0.001). There was significant symmetry between the new exudative lesion in the second eye and that in the first, and significant differences in the density and fluorescence of drusen in the second eye between the two groups. Conclusions. Patients with occult CNV with serous PED in the first eye have a significantly higher risk of visual loss in the second eye than patients with CNV without PED. This distinction may be important for future clinical studies. In addition, segregation of AMD by phenotype is necessary in the analysis of genes conferring risk of AMD.">
  <surfaceForm name="eye" offset="1293">
    <resource label="Human eye" uri="Human_eye" contextualScore="0.9999999999939746" percentageOfSecondRank="2.046130491742159E-12" support="3092" priorScore="2.5719324677078157E-5" finalScore="0.9999999999979536" types="DBpedia:AnatomicalStructure"/>
  </surfaceForm>
  <surfaceForm name="late" offset="606">
    <resource label="Radiation therapy" uri="Radiation_therapy" contextualScore="0.9999798289280155" percentageOfSecondRank="5.266357603540573E-5" support="1778" priorScore="1.4789443491541061E-5" finalScore="0.9999442629841206" types=""/>
  </surfaceForm>
  <surfaceForm name="Results" offset="634">
    <resource label="2008 Indian Premier League" uri="2008_Indian_Premier_League" contextualScore="0.5259287420525358" percentageOfSecondRank="0.0012813513110137994" support="117" priorScore="9.732085987122072E-7" finalScore="0.10759926967588639" types=""/>
    <resource label="Canadian federal election, 2006" uri="Canadian_federal_election,_2006" contextualScore="0.47244972440174493" percentageOfSecondRank="0.12059614130268238" support="1080" priorScore="8.983463988112681E-6" finalScore="0.8922281302999956" types="Schema:Event, DBpedia:Event, DBpedia:Election"/>
  </surfaceForm>
  <surfaceForm name="differences" offset="1064">
    <resource label="Sexual dimorphism" uri="Sexual_dimorphism" contextualScore="0.9968574139176494" percentageOfSecondRank="9.320974128294604E-4" support="1925" priorScore="1.6012192756589734E-5" finalScore="0.9989496696300758" types=""/>
  </surfaceForm>
  <surfaceForm name="reexamined" offset="454">
    <resource label="Reexamination" uri="Reexamination" contextualScore="0.9999999245180817" percentageOfSecondRank="0.0" support="50" priorScore="4.159011105607723E-7" finalScore="0.9999999983925818" types=""/>
  </surfaceForm>
  <surfaceForm name="CNV" offset="369">
    <resource label="Copy-number variation" uri="Copy-number_variation" contextualScore="1.0" percentageOfSecondRank="4.384717274973915E-19" support="132" priorScore="1.097978931880439E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="CNV" offset="881">
    <resource label="Copy-number variation" uri="Copy-number_variation" contextualScore="1.0" percentageOfSecondRank="4.384717274973915E-19" support="132" priorScore="1.097978931880439E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="pigment epithelium" offset="332">
    <resource label="Retinal pigment epithelium" uri="Retinal_pigment_epithelium" contextualScore="1.0" percentageOfSecondRank="0.0" support="83" priorScore="6.90395843530882E-7" finalScore="1.0" types="DBpedia:AnatomicalStructure"/>
  </surfaceForm>
  <surfaceForm name="In" offset="1396">
    <resource label="Indium" uri="Indium" contextualScore="0.3827796767341326" percentageOfSecondRank="0.08729264817597282" support="443" priorScore="3.6848838395684425E-6" finalScore="0.9146976980265057" types=""/>
  </surfaceForm>
  <surfaceForm name="CNV" offset="407">
    <resource label="Copy-number variation" uri="Copy-number_variation" contextualScore="1.0" percentageOfSecondRank="4.384717274973915E-19" support="132" priorScore="1.097978931880439E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="group" offset="373">
    <resource label="Social group" uri="Social_group" contextualScore="0.9391252700685849" percentageOfSecondRank="6.409744677353784E-4" support="1242" priorScore="1.0330983586329584E-5" finalScore="0.13574689670268672" types=""/>
    <resource label="Group (mathematics)" uri="Group_(mathematics)" contextualScore="0.057006322954475865" percentageOfSecondRank="0.1570843535621002" support="9593" priorScore="7.979478707218977E-5" finalScore="0.8641656130890328" types=""/>
  </surfaceForm>
  <surfaceForm name="phenotype" offset="1431">
    <resource label="Phenotype" uri="Phenotype" contextualScore="0.9999999938015662" percentageOfSecondRank="6.443563563652019E-13" support="2021" priorScore="1.6810722888866415E-5" finalScore="0.9999999999993179" types=""/>
  </surfaceForm>
  <surfaceForm name="Of" offset="217">
    <resource label="Of, Turkey" uri="Of,_Turkey" contextualScore="0.001352292455044894" percentageOfSecondRank="0.0" support="26" priorScore="2.1626857749160158E-7" finalScore="0.10927724975259101" types="Schema:Place, DBpedia:Place, DBpedia:PopulatedPlace, DBpedia:Settlement"/>
  </surfaceForm>
  <surfaceForm name="Purpose" offset="9">
    <resource label="Intention" uri="Intention" contextualScore="0.9999999238109496" percentageOfSecondRank="0.0" support="302" priorScore="2.5120427077870646E-6" finalScore="0.9999999997196483" types=""/>
  </surfaceForm>
  <surfaceForm name="late" offset="162">
    <resource label="Radiation therapy" uri="Radiation_therapy" contextualScore="0.9999798289280155" percentageOfSecondRank="5.266357603540573E-5" support="1778" priorScore="1.4789443491541061E-5" finalScore="0.9999442629841206" types=""/>
  </surfaceForm>
  <surfaceForm name="CNV" offset="1316">
    <resource label="Copy-number variation" uri="Copy-number_variation" contextualScore="1.0" percentageOfSecondRank="4.384717274973915E-19" support="132" priorScore="1.097978931880439E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="Methods" offset="208">
    <resource label="Scientific method" uri="Scientific_method" contextualScore="0.9999995067299858" percentageOfSecondRank="1.4093434794785358E-6" support="1645" priorScore="1.3683146537449409E-5" finalScore="0.9999985906584624" types=""/>
  </surfaceForm>
  <surfaceForm name="late" offset="854">
    <resource label="Radiation therapy" uri="Radiation_therapy" contextualScore="0.9999798289280155" percentageOfSecondRank="5.266357603540573E-5" support="1778" priorScore="1.4789443491541061E-5" finalScore="0.9999442629841206" types=""/>
  </surfaceForm>
  <surfaceForm name="patients" offset="137">
    <resource label="Patient" uri="Patient" contextualScore="0.9999999996456381" percentageOfSecondRank="2.0253965846016722E-13" support="2793" priorScore="2.323223603592474E-5" finalScore="0.9999999999997726" types=""/>
  </surfaceForm>
  <surfaceForm name="PED" offset="1210">
    <resource label="Performance-enhancing drugs" uri="Performance-enhancing_drugs" contextualScore="0.9966454289333289" percentageOfSecondRank="1.6147037504141038E-5" support="260" priorScore="2.1626857749160156E-6" finalScore="0.9999789812314969" types=""/>
  </surfaceForm>
  <surfaceForm name="prospective" offset="20">
    <resource label="Prospective cohort study" uri="Prospective_cohort_study" contextualScore="0.9999999999998863" percentageOfSecondRank="1.8884645296711776E-14" support="43" priorScore="3.576749550822642E-7" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="exudative" offset="257">
    <resource label="Exudate" uri="Exudate" contextualScore="1.0" percentageOfSecondRank="0.0" support="170" priorScore="1.4140637759066257E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="type" offset="846">
    <resource label="Data type" uri="Data_type" contextualScore="0.2533974943316871" percentageOfSecondRank="0.09839881578817959" support="1375" priorScore="1.1437280540421237E-5" finalScore="0.2287788115094144" types=""/>
    <resource label="Type species" uri="Type_species" contextualScore="0.37669030518436913" percentageOfSecondRank="0.767886788489261" support="3696" priorScore="3.074341009265229E-5" finalScore="0.2979329960338468" types=""/>
    <resource label="Type (biology)" uri="Type_(biology)" contextualScore="0.23939520443338844" percentageOfSecondRank="0.6621725570835805" support="3820" priorScore="3.1774844846843E-5" finalScore="0.44993256341827115" types=""/>
  </surfaceForm>
  <surfaceForm name="serous" offset="1203">
    <resource label="Serous fluid" uri="Serous_fluid" contextualScore="0.9999999999602096" percentageOfSecondRank="1.871802199880578E-12" support="62" priorScore="5.157173770953576E-7" finalScore="0.99999999999784" types=""/>
  </surfaceForm>
  <surfaceForm name="visual loss" offset="1267">
    <resource label="Vision loss" uri="Vision_loss" contextualScore="1.0" percentageOfSecondRank="0.0" support="114" priorScore="9.482545320785608E-7" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="genes" offset="1473">
    <resource label="Gene" uri="Gene" contextualScore="0.9979876263056648" percentageOfSecondRank="8.828709840418687E-7" support="30058" priorScore="2.5002311162471385E-4" finalScore="0.9999991159081034" types=""/>
  </surfaceForm>
  <surfaceForm name="lesion" offset="1000">
    <resource label="Lesion" uri="Lesion" contextualScore="0.9999999978317646" percentageOfSecondRank="2.9991049377144515E-12" support="1500" priorScore="1.2477033316823168E-5" finalScore="0.9999999999970441" types=""/>
  </surfaceForm>
  <surfaceForm name="AMD" offset="1424">
    <resource label="Advanced Micro Devices" uri="Advanced_Micro_Devices" contextualScore="0.9891666157930228" percentageOfSecondRank="1.828771453939352E-6" support="2018" priorScore="1.6785768822232768E-5" finalScore="0.9999978588514481" types="DBpedia:Agent, Schema:Organization, DBpedia:Organisation, DBpedia:Company"/>
  </surfaceForm>
  <surfaceForm name="point" offset="696">
    <resource label="Point (geometry)" uri="Point_(geometry)" contextualScore="0.7573147837780396" percentageOfSecondRank="6.4118266602714E-4" support="2055" priorScore="1.709353564404774E-5" finalScore="0.9993543255890449" types=""/>
  </surfaceForm>
  <surfaceForm name="occult" offset="1187">
    <resource label="Occult" uri="Occult" contextualScore="0.0036071765017143325" percentageOfSecondRank="0.004383187420338551" support="1935" priorScore="1.6095372978701886E-5" finalScore="0.9925475164632059" types=""/>
  </surfaceForm>
  <surfaceForm name="PED" offset="363">
    <resource label="Performance-enhancing drugs" uri="Performance-enhancing_drugs" contextualScore="0.9966454289333289" percentageOfSecondRank="1.6147037504141038E-5" support="260" priorScore="2.1626857749160156E-6" finalScore="0.9999789812314969" types=""/>
  </surfaceForm>
  <surfaceForm name="exudative" offset="990">
    <resource label="Exudate" uri="Exudate" contextualScore="1.0" percentageOfSecondRank="0.0" support="170" priorScore="1.4140637759066257E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="AMD" offset="1498">
    <resource label="Advanced Micro Devices" uri="Advanced_Micro_Devices" contextualScore="0.9891666157930228" percentageOfSecondRank="1.828771453939352E-6" support="2018" priorScore="1.6785768822232768E-5" finalScore="0.9999978588514481" types="DBpedia:Agent, Schema:Organization, DBpedia:Organisation, DBpedia:Company"/>
  </surfaceForm>
  <surfaceForm name="disease" offset="189">
    <resource label="Disease" uri="Disease" contextualScore="0.9916309427596318" percentageOfSecondRank="3.999886938261294E-5" support="7304" priorScore="6.0754834230717615E-5" finalScore="0.9999599378975211" types=""/>
  </surfaceForm>
  <surfaceForm name="eye" offset="629">
    <resource label="Human eye" uri="Human_eye" contextualScore="0.9999999999939746" percentageOfSecondRank="2.046130491742159E-12" support="3092" priorScore="2.5719324677078157E-5" finalScore="0.9999999999979536" types="DBpedia:AnatomicalStructure"/>
  </surfaceForm>
  <surfaceForm name="group 15" offset="910">
    <resource label="Group (periodic table)" uri="Group_(periodic_table)" contextualScore="0.21508691833142904" percentageOfSecondRank="0.0" support="344" priorScore="2.8613996406581135E-6" finalScore="0.21054420654582298" types=""/>
    <resource label="Pnictogen" uri="Pnictogen" contextualScore="0.78481544484129" percentageOfSecondRank="0.2666953726733486" support="101" priorScore="8.4012024333276E-7" finalScore="0.7894557915847299" types=""/>
  </surfaceForm>
  <surfaceForm name="initiated" offset="55">
    <resource label="Initiation" uri="Initiation" contextualScore="0.9503789055091049" percentageOfSecondRank="1.765149684438063E-4" support="619" priorScore="5.148855748742361E-6" finalScore="0.9996877344365038" types=""/>
  </surfaceForm>
  <surfaceForm name="unilateral" offset="241">
    <resource label="Unilateralism" uri="Unilateralism" contextualScore="0.8220329749974251" percentageOfSecondRank="0.0775001657037315" support="172" priorScore="1.4306998203290567E-6" finalScore="0.9262834793535386" types=""/>
  </surfaceForm>
  <surfaceForm name="patients" offset="1302">
    <resource label="Patient" uri="Patient" contextualScore="0.9999999996456381" percentageOfSecondRank="2.0253965846016722E-13" support="2793" priorScore="2.323223603592474E-5" finalScore="0.9999999999997726" types=""/>
  </surfaceForm>
  <surfaceForm name="groups" offset="1152">
    <resource label="Social group" uri="Social_group" contextualScore="0.9391257123986331" percentageOfSecondRank="6.550649243516287E-4" support="1242" priorScore="1.0330983586329584E-5" finalScore="0.30242330442390936" types=""/>
    <resource label="Group (mathematics)" uri="Group_(mathematics)" contextualScore="0.057006349804578166" percentageOfSecondRank="0.43365732514882965" support="9593" priorScore="7.979478707218977E-5" finalScore="0.6973785219011779" types=""/>
  </surfaceForm>
  <surfaceForm name="phenotype" offset="197">
    <resource label="Phenotype" uri="Phenotype" contextualScore="0.9999999938015662" percentageOfSecondRank="6.443563563652019E-13" support="2021" priorScore="1.6810722888866415E-5" finalScore="0.9999999999993179" types=""/>
  </surfaceForm>
  <surfaceForm name="CNV" offset="721">
    <resource label="Copy-number variation" uri="Copy-number_variation" contextualScore="1.0" percentageOfSecondRank="4.384717274973915E-19" support="132" priorScore="1.097978931880439E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="PED" offset="906">
    <resource label="Performance-enhancing drugs" uri="Performance-enhancing_drugs" contextualScore="0.9966454289333289" percentageOfSecondRank="1.6147037504141038E-5" support="260" priorScore="2.1626857749160156E-6" finalScore="0.9999789812314969" types=""/>
  </surfaceForm>
  <surfaceForm name="The" offset="535">
    <resource label="English articles" uri="English_articles" contextualScore="0.14043650792273102" percentageOfSecondRank="0.04066542128804351" support="5094" priorScore="4.237200514393148E-5" finalScore="0.9583171965570599" types=""/>
  </surfaceForm>
  <surfaceForm name="prognostic factor" offset="774">
    <resource label="Prognosis" uri="Prognosis" contextualScore="1.0" percentageOfSecondRank="0.0" support="674" priorScore="5.6063469703592105E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="AMD" offset="177">
    <resource label="Advanced Micro Devices" uri="Advanced_Micro_Devices" contextualScore="0.9891666157930228" percentageOfSecondRank="1.828771453939352E-6" support="2018" priorScore="1.6785768822232768E-5" finalScore="0.9999978588514481" types="DBpedia:Agent, Schema:Organization, DBpedia:Organisation, DBpedia:Company"/>
  </surfaceForm>
  <surfaceForm name="CNV" offset="320">
    <resource label="Copy-number variation" uri="Copy-number_variation" contextualScore="1.0" percentageOfSecondRank="4.384717274973915E-19" support="132" priorScore="1.097978931880439E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="point" offset="543">
    <resource label="Point (geometry)" uri="Point_(geometry)" contextualScore="0.7573147837780396" percentageOfSecondRank="6.4118266602714E-4" support="2055" priorScore="1.709353564404774E-5" finalScore="0.9993543255890449" types=""/>
  </surfaceForm>
  <surfaceForm name="patients" offset="227">
    <resource label="Patient" uri="Patient" contextualScore="0.9999999996456381" percentageOfSecondRank="2.0253965846016722E-13" support="2793" priorScore="2.323223603592474E-5" finalScore="0.9999999999997726" types=""/>
  </surfaceForm>
  <surfaceForm name="higher" offset="1252">
    <resource label="Higher education" uri="Higher_education" contextualScore="0.0013104268000069023" percentageOfSecondRank="4.6345457533445155E-4" support="4912" priorScore="4.085812510149027E-5" finalScore="0.29860494579098695" types=""/>
    <resource label="Dose–response relationship" uri="Dose–response_relationship" contextualScore="0.9981402887386656" percentageOfSecondRank="0.4258647693889562" support="106" priorScore="8.817103543888372E-7" finalScore="0.7011731593093142" types=""/>
  </surfaceForm>
  <surfaceForm name="eye" offset="1021">
    <resource label="Human eye" uri="Human_eye" contextualScore="0.9999999999939746" percentageOfSecondRank="2.046130491742159E-12" support="3092" priorScore="2.5719324677078157E-5" finalScore="0.9999999999979536" types="DBpedia:AnatomicalStructure"/>
  </surfaceForm>
  <surfaceForm name="reached" offset="680">
    <resource label="2008–09 UEFA Cup" uri="2008–09_UEFA_Cup" contextualScore="0.031050445653068203" percentageOfSecondRank="0.5368401169033675" support="512" priorScore="4.258827372142308E-6" finalScore="0.10916209473457064" types=""/>
    <resource label="2006–07 UEFA Cup" uri="2006–07_UEFA_Cup" contextualScore="0.0919336486513238" percentageOfSecondRank="0.30806507785135184" support="421" priorScore="3.5018873509217027E-6" finalScore="0.3543475148041407" types=""/>
    <resource label="1986 NBA Finals" uri="1986_NBA_Finals" contextualScore="0.8446462834754367" percentageOfSecondRank="0.7450863398714714" support="123" priorScore="1.0231167319794998E-6" finalScore="0.47557913203088137" types=""/>
  </surfaceForm>
  <surfaceForm name="AMD" offset="611">
    <resource label="Advanced Micro Devices" uri="Advanced_Micro_Devices" contextualScore="0.9891666157930228" percentageOfSecondRank="1.828771453939352E-6" support="2018" priorScore="1.6785768822232768E-5" finalScore="0.9999978588514481" types="DBpedia:Agent, Schema:Organization, DBpedia:Organisation, DBpedia:Company"/>
  </surfaceForm>
  <surfaceForm name="eye" offset="876">
    <resource label="Human eye" uri="Human_eye" contextualScore="0.9999999999939746" percentageOfSecondRank="2.046130491742159E-12" support="3092" priorScore="2.5719324677078157E-5" finalScore="0.9999999999979536" types="DBpedia:AnatomicalStructure"/>
  </surfaceForm>
  <surfaceForm name="eye" offset="1132">
    <resource label="Human eye" uri="Human_eye" contextualScore="0.9999999999939746" percentageOfSecondRank="2.046130491742159E-12" support="3092" priorScore="2.5719324677078157E-5" finalScore="0.9999999999979536" types="DBpedia:AnatomicalStructure"/>
  </surfaceForm>
  <surfaceForm name="PED" offset="428">
    <resource label="Performance-enhancing drugs" uri="Performance-enhancing_drugs" contextualScore="0.9966454289333289" percentageOfSecondRank="1.6147037504141038E-5" support="260" priorScore="2.1626857749160156E-6" finalScore="0.9999789812314969" types=""/>
  </surfaceForm>
  <surfaceForm name="CNV" offset="1194">
    <resource label="Copy-number variation" uri="Copy-number_variation" contextualScore="1.0" percentageOfSecondRank="4.384717274973915E-19" support="132" priorScore="1.097978931880439E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="ophthalmoscopy" offset="468">
    <resource label="Ophthalmoscopy" uri="Ophthalmoscopy" contextualScore="1.0" percentageOfSecondRank="0.0" support="147" priorScore="1.2227492650486706E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="group" offset="757">
    <resource label="Social group" uri="Social_group" contextualScore="0.9391252700685849" percentageOfSecondRank="6.409744677353784E-4" support="1242" priorScore="1.0330983586329584E-5" finalScore="0.13574689670268672" types=""/>
    <resource label="Group (mathematics)" uri="Group_(mathematics)" contextualScore="0.057006322954475865" percentageOfSecondRank="0.1570843535621002" support="9593" priorScore="7.979478707218977E-5" finalScore="0.8641656130890328" types=""/>
  </surfaceForm>
  <surfaceForm name="patients" offset="671">
    <resource label="Patient" uri="Patient" contextualScore="0.9999999996456381" percentageOfSecondRank="2.0253965846016722E-13" support="2793" priorScore="2.323223603592474E-5" finalScore="0.9999999999997726" types=""/>
  </surfaceForm>
  <surfaceForm name="addition" offset="1399">
    <resource label="Euclidean vector" uri="Euclidean_vector" contextualScore="0.8645795504328151" percentageOfSecondRank="0.021149982195803257" support="3950" priorScore="3.285618773430101E-5" finalScore="0.34853326045439326" types=""/>
    <resource label="Addition" uri="Addition" contextualScore="0.05904457869876251" percentageOfSecondRank="0.541215568597263" support="727" priorScore="6.047202147553629E-6" finalScore="0.6439823254858152" types=""/>
  </surfaceForm>
  <surfaceForm name="correlation" offset="80">
    <resource label="Correlation and dependence" uri="Correlation_and_dependence" contextualScore="0.9992728041771288" percentageOfSecondRank="1.8543039893939096E-7" support="1882" priorScore="1.5654517801507468E-5" finalScore="0.999999644676172" types=""/>
  </surfaceForm>
  <surfaceForm name="visual acuity" offset="559">
    <resource label="Visual acuity" uri="Visual_acuity" contextualScore="1.0" percentageOfSecondRank="1.9796764625829118E-23" support="457" priorScore="3.8013361505254586E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="longitudinal study" offset="32">
    <resource label="Longitudinal study" uri="Longitudinal_study" contextualScore="1.0" percentageOfSecondRank="0.0" support="281" priorScore="2.3373642413515403E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="PED" offset="423">
    <resource label="Performance-enhancing drugs" uri="Performance-enhancing_drugs" contextualScore="0.9966454289333289" percentageOfSecondRank="1.6147037504141038E-5" support="260" priorScore="2.1626857749160156E-6" finalScore="0.9999789812314969" types=""/>
  </surfaceForm>
  <surfaceForm name="classic" offset="312">
    <resource label="Classical antiquity" uri="Classical_antiquity" contextualScore="0.6893668280843779" percentageOfSecondRank="0.07063892521388784" support="2368" priorScore="1.9697076596158176E-5" finalScore="0.8167784910753924" types=""/>
  </surfaceForm>
  <surfaceForm name="late" offset="252">
    <resource label="Radiation therapy" uri="Radiation_therapy" contextualScore="0.9999798289280155" percentageOfSecondRank="5.266357603540573E-5" support="1778" priorScore="1.4789443491541061E-5" finalScore="0.9999442629841206" types=""/>
  </surfaceForm>
  <surfaceForm name="detachment" offset="351">
    <resource label="Detachment (military)" uri="Detachment_(military)" contextualScore="0.7738547773753642" percentageOfSecondRank="0.001326808695679134" support="254" priorScore="2.112777641648723E-6" finalScore="0.997790943505902" types=""/>
  </surfaceForm>
  <surfaceForm name="lines" offset="585">
    <resource label="Line (geometry)" uri="Line_(geometry)" contextualScore="0.9993698626454797" percentageOfSecondRank="6.283057243141747E-5" support="1705" priorScore="1.4182227870122335E-5" finalScore="0.9999351162503151" types=""/>
  </surfaceForm>
  <surfaceForm name="future" offset="1371">
    <resource label="Futures contract" uri="Futures_contract" contextualScore="0.7079594206615636" percentageOfSecondRank="0.4673595475730023" support="1144" priorScore="9.515817409630469E-6" finalScore="0.13822233551078578" types=""/>
    <resource label="Future" uri="Future" contextualScore="0.05707704545957967" percentageOfSecondRank="0.18333827573707492" support="949" priorScore="7.893803078443457E-6" finalScore="0.7539196872834681" types=""/>
  </surfaceForm>
  <surfaceForm name="Conclusions" offset="1160">
    <resource label="Logical consequence" uri="Logical_consequence" contextualScore="0.9999999998422027" percentageOfSecondRank="0.0" support="602" priorScore="5.007449371151698E-6" finalScore="0.9999999999994316" types=""/>
  </surfaceForm>
  <surfaceForm name="eye" offset="834">
    <resource label="Human eye" uri="Human_eye" contextualScore="0.9999999999939746" percentageOfSecondRank="2.046130491742159E-12" support="3092" priorScore="2.5719324677078157E-5" finalScore="0.9999999999979536" types="DBpedia:AnatomicalStructure"/>
  </surfaceForm>
  <surfaceForm name="PED" offset="753">
    <resource label="Performance-enhancing drugs" uri="Performance-enhancing_drugs" contextualScore="0.9966454289333289" percentageOfSecondRank="1.6147037504141038E-5" support="260" priorScore="2.1626857749160156E-6" finalScore="0.9999789812314969" types=""/>
  </surfaceForm>
  <surfaceForm name="group" offset="725">
    <resource label="Social group" uri="Social_group" contextualScore="0.9391252700685849" percentageOfSecondRank="6.409744677353784E-4" support="1242" priorScore="1.0330983586329584E-5" finalScore="0.13574689670268672" types=""/>
    <resource label="Group (mathematics)" uri="Group_(mathematics)" contextualScore="0.057006322954475865" percentageOfSecondRank="0.1570843535621002" support="9593" priorScore="7.979478707218977E-5" finalScore="0.8641656130890328" types=""/>
  </surfaceForm>
  <surfaceForm name="group" offset="432">
    <resource label="Social group" uri="Social_group" contextualScore="0.9391252700685849" percentageOfSecondRank="6.409744677353784E-4" support="1242" priorScore="1.0330983586329584E-5" finalScore="0.13574689670268672" types=""/>
    <resource label="Group (mathematics)" uri="Group_(mathematics)" contextualScore="0.057006322954475865" percentageOfSecondRank="0.1570843535621002" support="9593" priorScore="7.979478707218977E-5" finalScore="0.8641656130890328" types=""/>
  </surfaceForm>
  <surfaceForm name="density" offset="1083">
    <resource label="Density" uri="Density" contextualScore="0.8725257999375093" percentageOfSecondRank="3.46180297664973E-5" support="3861" priorScore="3.2115883757502834E-5" finalScore="0.999964762352209" types=""/>
  </surfaceForm>
  <surfaceForm name="eyes" offset="129">
    <resource label="Human eye" uri="Human_eye" contextualScore="0.999999999994202" percentageOfSecondRank="6.59288729605786E-12" support="3092" priorScore="2.5719324677078157E-5" finalScore="0.9999999999934062" types="DBpedia:AnatomicalStructure"/>
  </surfaceForm>
  <surfaceForm name="occult" offset="400">
    <resource label="Occult" uri="Occult" contextualScore="0.0036071765017143325" percentageOfSecondRank="0.004383187420338551" support="1935" priorScore="1.6095372978701886E-5" finalScore="0.9925475164632059" types=""/>
  </surfaceForm>
  <surfaceForm name="symmetry" offset="965">
    <resource label="Symmetry" uri="Symmetry" contextualScore="0.043489682029525224" percentageOfSecondRank="0.07004119791928747" support="2270" priorScore="1.888191041945906E-5" finalScore="0.9344743017415941" types=""/>
  </surfaceForm>
  <surfaceForm name="exudative" offset="167">
    <resource label="Exudate" uri="Exudate" contextualScore="1.0" percentageOfSecondRank="0.0" support="170" priorScore="1.4140637759066257E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="change" offset="573">
    <resource label="Calculus" uri="Calculus" contextualScore="0.08165321192185371" percentageOfSecondRank="0.021972992244394956" support="1657" priorScore="1.3782962803983993E-5" finalScore="0.42877510904660066" types=""/>
    <resource label="Eye color" uri="Eye_color" contextualScore="0.9154913455408059" percentageOfSecondRank="0.7657451048109414" support="193" priorScore="1.605378286764581E-6" finalScore="0.5599449560339835" types=""/>
  </surfaceForm>
  <surfaceForm name="angiography" offset="487">
    <resource label="Angiography" uri="Angiography" contextualScore="0.9999972024499381" percentageOfSecondRank="1.0049445963560286E-9" support="351" priorScore="2.9196257961366213E-6" finalScore="0.9999999989950084" types=""/>
  </surfaceForm>
  <surfaceForm name="The major" offset="764">
    <resource label="List of Hellsing characters" uri="List_of_Hellsing_characters" contextualScore="0.49091510374082153" percentageOfSecondRank="0.006814095805438921" support="600" priorScore="4.990813326729267E-6" finalScore="0.9932320141984509" types=""/>
  </surfaceForm>
  <surfaceForm name="There" offset="943">
    <resource label="France" uri="France" contextualScore="0.21380728507013363" percentageOfSecondRank="0.02989361593436458" support="205641" priorScore="0.0017105264055365555" finalScore="0.9709464774385744" types="Schema:Place, DBpedia:Place, DBpedia:PopulatedPlace, Schema:Country, DBpedia:Country"/>
  </surfaceForm>
  <surfaceForm name="AMD" offset="859">
    <resource label="Advanced Micro Devices" uri="Advanced_Micro_Devices" contextualScore="0.9891666157930228" percentageOfSecondRank="1.828771453939352E-6" support="2018" priorScore="1.6785768822232768E-5" finalScore="0.9999978588514481" types="DBpedia:Agent, Schema:Organization, DBpedia:Organisation, DBpedia:Company"/>
  </surfaceForm>
  <surfaceForm name="fluorescence" offset="1095">
    <resource label="Fluorescence" uri="Fluorescence" contextualScore="0.23758490272026528" percentageOfSecondRank="0.0016684393653102242" support="2255" priorScore="1.875714008629083E-5" finalScore="0.9983232361235825" types=""/>
  </surfaceForm>
  <surfaceForm name="Patients" offset="440">
    <resource label="Patient" uri="Patient" contextualScore="0.9999999999997726" percentageOfSecondRank="1.3817669754906982E-15" support="2793" priorScore="2.323223603592474E-5" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="unilateral" offset="151">
    <resource label="Unilateralism" uri="Unilateralism" contextualScore="0.8220329749974251" percentageOfSecondRank="0.0775001657037315" support="172" priorScore="1.4306998203290567E-6" finalScore="0.9262834793535386" types=""/>
  </surfaceForm>
  <surfaceForm name="AMD" offset="267">
    <resource label="Advanced Micro Devices" uri="Advanced_Micro_Devices" contextualScore="0.9891666157930228" percentageOfSecondRank="1.828771453939352E-6" support="2018" priorScore="1.6785768822232768E-5" finalScore="0.9999978588514481" types="DBpedia:Agent, Schema:Organization, DBpedia:Organisation, DBpedia:Company"/>
  </surfaceForm>
  <surfaceForm name="PED" offset="1328">
    <resource label="Performance-enhancing drugs" uri="Performance-enhancing_drugs" contextualScore="0.9966454289333289" percentageOfSecondRank="1.6147037504141038E-5" support="260" priorScore="2.1626857749160156E-6" finalScore="0.9999789812314969" types=""/>
  </surfaceForm>
  <surfaceForm name="Abstract" offset="0">
    <resource label="Abstract art" uri="Abstract_art" contextualScore="0.011001169759012237" percentageOfSecondRank="0.16946682410982378" support="1865" priorScore="1.5513111423916808E-5" finalScore="0.32466877957047346" types=""/>
    <resource label="Abstraction" uri="Abstraction" contextualScore="0.4783133373993684" percentageOfSecondRank="0.5481770700072646" support="626" priorScore="5.207081904220869E-6" finalScore="0.5922699020704585" types=""/>
  </surfaceForm>
  <surfaceForm name="group 6" offset="885">
    <resource label="IB Group 6 subjects" uri="IB_Group_6_subjects" contextualScore="0.9973745642093655" percentageOfSecondRank="0.006456338294239472" support="22" priorScore="1.829964886467398E-7" finalScore="0.993585077941794" types=""/>
  </surfaceForm>
  <surfaceForm name="eye" offset="1227">
    <resource label="Human eye" uri="Human_eye" contextualScore="0.9999999999939746" percentageOfSecondRank="2.046130491742159E-12" support="3092" priorScore="2.5719324677078157E-5" finalScore="0.9999999999979536" types="DBpedia:AnatomicalStructure"/>
  </surfaceForm>
  <surfaceForm name="This" offset="1333">
    <resource label="Breast" uri="Breast" contextualScore="0.9999999916110482" percentageOfSecondRank="1.5440366147261878E-9" support="3027" priorScore="2.5178653233349152E-5" finalScore="0.9999999983100452" types="DBpedia:AnatomicalStructure"/>
  </surfaceForm>
  <surfaceForm name="visual loss" offset="808">
    <resource label="Vision loss" uri="Vision_loss" contextualScore="1.0" percentageOfSecondRank="0.0" support="114" priorScore="9.482545320785608E-7" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="serous" offset="416">
    <resource label="Serous fluid" uri="Serous_fluid" contextualScore="0.9999999999602096" percentageOfSecondRank="1.871802199880578E-12" support="62" priorScore="5.157173770953576E-7" finalScore="0.99999999999784" types=""/>
  </surfaceForm>
  <surfaceForm name="Patients" offset="1173">
    <resource label="Patient" uri="Patient" contextualScore="0.9999999999997726" percentageOfSecondRank="1.3817669754906982E-15" support="2793" priorScore="2.323223603592474E-5" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="clinical studies" offset="1378">
    <resource label="Clinical trial" uri="Clinical_trial" contextualScore="0.9999738369834325" percentageOfSecondRank="7.740308572511127E-6" support="2041" priorScore="1.6977083333090723E-5" finalScore="0.9999922597513086" types=""/>
  </surfaceForm>
  <surfaceForm name="prognosis" offset="104">
    <resource label="Prognosis" uri="Prognosis" contextualScore="0.999999584846905" percentageOfSecondRank="4.974752862126935E-10" support="674" priorScore="5.6063469703592105E-6" finalScore="0.9999999995025064" types=""/>
  </surfaceForm>
  <surfaceForm name="segregation" offset="1409">
    <resource label="Mendelian inheritance" uri="Mendelian_inheritance" contextualScore="0.9999999998143494" percentageOfSecondRank="2.8693183408552185E-9" support="409" priorScore="3.402071084387117E-6" finalScore="0.9999999960467676" types=""/>
  </surfaceForm>
</annotation>